Related Experiment Video
Updated: Aug 28, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Children's and young People's diabetes services: What works well and what doesn't?
N Kime1, S Zwolinsky2, A Pringle3
1Academic Unit for Ageing and Stroke Research, Bradford Institute for Health Research, Temple Bank House, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, BD9 6RJ, United Kingdom.
Insights
The first year of care for type 1 diabetes is crucial. This study found that a structured intervention improved care, but children need more social support for self-management.
Area of Science:
- Pediatrics
- Endocrinology
- Public Health
Background:
- The initial year post-diagnosis is critical for pediatric type 1 diabetes management.
- Effective interventions are needed to optimize care for newly diagnosed children and young people.
Purpose of the Study:
- To evaluate a "First Year of Care" intervention for pediatric type 1 diabetes.
- To identify strengths and challenges in delivering this intervention.
Main Methods:
- Observational mixed-methods study using the Influencer Framework.
- Included medical records, semi-structured interviews, and questionnaires from 32 children/young people and healthcare professionals.
Main Results:
- Many participants achieved optimal HbA1c levels within the first year.
- Positive practices included cohesive teams, patient-centered care, technology, and structured education.
- Healthcare professionals had higher influence scores than children, indicating a need for enhanced social support.
Conclusions:
- The "First Year of Care" intervention shows potential for managing type 1 diabetes.
- Layered approaches to behavior change are effective across multiple influence domains.
- Enhancing social motivation and support is vital for long-term engagement and improved outcomes.
Objectives:
The first year of care, post diagnosis, is pivotal for children and young people diagnosed with type 1 diabetes. This study evaluated a paediatric type 1 diabetes intervention, the 'First Year of Care', designed to maximise the care that newly diagnosed children and young people received.
Study Design:
An observational mixed methods approach, underpinned by the Influencer Framework.
Methods:
A purposeful, non-probability sample of children and young people with type 1 diabetes and their families, and healthcare professionals were invited to take part. Data were collected through medical records of thirty-two newly diagnosed children and young people, plus thirty seven semi-structured interviews and exposure to six concurrent sources of influence through a questionnaire.
Results:
For many participants, HbA1c levels were within the optimal range by the time of their first clinic visit post-diagnosis and continued to stay within this range throughout the first year of care. Healthcare professionals prioritised the 'First Year of Care' intervention. Positive practices included: a cohesive and collaborative approach; patient-centred care; latest health technology and embedded structured education. Unusually, different multidisciplinary team members were located in one place.Data indicated statistically significant differences in total sources of influence score (t [35] = 2.331, p = 0.026); healthcare professionals' scores were higher compared to children. This suggests that children and young people have less social capital to self-manage their diabetes effectively. Greater encouragement and assistance from healthcare professionals and social networks may be needed.
Conclusions:
This paper identifies contemporary issues in practice and highlights the strengths and challenges for a paediatric diabetes intervention. The findings confirm the potential of layered approaches to behaviour change in managing type 1 diabetes across multiple domains of influence. Our study strongly suggests enhancing social motivation among children, young people and families to support successful long-term engagement in a paediatric diabetes intervention. Findings demonstrate healthcare professionals are key in delivering the intervention, along with opportunities to improve patient care, experience and outcomes.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

